Liran Tiosano

Dr. Liran Tiosano


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 January 2021 in Eye
Verified
Journal Article
Closed access
PDF file
LTLiran Tiosano
Liran Tiosano
GCGiulia Corradetti
Giulia Corradetti
SSSRINIVAS R SADDA
SRINIVAS R SADDA

10 November 2020 in British Journal of Ophthalmology
Verified
Journal Article
Closed access
PDF file
GCGiulia Corradetti
Giulia Corradetti
LTLiran Tiosano
Liran Tiosano
MNMarco Nassisi
Marco Nassisi
AAAhmed Roshdy Alagorie
Ahmed Roshdy Alagorie
FCFederico Corvi
Federico Corvi
SSSRINIVAS R SADDA
SRINIVAS R SADDA
Background/Aims: To assess the role of microperimetric retinal sensitivity (MPRS) and inner choroid flow deficits (IC FD) in predicting the development of incomplete retinal pigment epithelial and outer retinal atrophy (iRORA) in intermediate AMD (i-AMD). Methods: Thirty eyes with i-AMD evaluated at the Doheny-UCLA Eye Centres were enrolled in this prospective IRB-approved study. Subjects underwent several diagnostic tests: (a) 6×6 mm swept-source optical coherence tomography angiography (SS-OCTA) with the IC slab used to quantify the FDs, (b) 20°×20° spectral-domain optical coherence tomography (SD-OCT) to monitor progression to iRORA and (c) scotopic MPRS within an area of 18° centred on the fovea. All subjects were followed-up for 24 months. The baseline IC FD and MPRS were correlated with the development of iRORA. At 24-month follow-up, the stage of AMD was re-assessed and the eyes were divided into two sub-groups based on the development of iRORA. Results: Twenty-eight eyes completed the 2-year follow-up. At baseline, the mean MPRS was 13.40±4.66 dB and the mean IC FD was 27.55±8.67%. The morpho-functional regression showed a significant correlation between baseline MPRS and IC FD and the development of iRORA within 24 months (R 2 =0.744, p<0.05). A Kaplan–Meier survival curve was fit to determine the cumulative incidence of iRORA over the 24 months. Conclusions: A lower MPRS and greater IC FD at baseline were predictors of progression to iRORA in eyes with i-AMD. These parameters may be useful biomarkers for risk stratification and prognostication.

21 October 2023 in Eye
Verified
Journal Article
Open access
PDF file
AAAhmed Roshdy Alagorie
Ahmed Roshdy Alagorie
GCGiulia Corradetti
Giulia Corradetti
IBIksoo Byon
Iksoo Byon
LTLiran Tiosano
Liran Tiosano
YJYongsok Ji
Yongsok Ji
SSSRINIVAS R SADDA
SRINIVAS R SADDA
Objective: To evaluate the effect of changing slab position on the correlation between choriocapillaris (CC) flow deficits (FD) in eyes with geographic atrophy (GA) and yearly enlargement rate (yER) of GA. Methods: OCT and OCTA images obtained on Cirrus HD-OCT device were collected from patients with GA. Each patient underwent OCTA scan at baseline and two OCT scans, one at baseline and one after at least 12 months. GA was delineated on en-face fundus image to calculate yER. OCTA images were generated from three 10 µm thick slabs 11, 21 and 31 µm posterior to RPE-fit line. 100 µm-wide concentric rings were generated around GA to calculate FD% in each ring which was correlated with yER. Results: For the 11–21 µm slab, FD% was not significantly correlated with yER for any of the rings (p > 0.05). For the 21–31 and 31–41 µm slab, FD% of rings located in the 600 µm region around GA was significantly correlated with yER (p < 0.05). However, in all slab locations, there was no significant correlation between yER and CC FD% of rings located beyond the 600 µm region (p > 0.05). Conclusions: Slab selection for quantification of CC FD% may have a significant impact on quantitative results in eyes with GA.

Verified
Journal Article
Open access
PDF file
LTLiran Tiosano
Liran Tiosano
RARon Abutbul
Ron Abutbul
RLRivkah Lender
Rivkah Lender
YSYahel Shwartz
Yahel Shwartz
ICItay Chowers
Itay Chowers
JLJaime Levy
Jaime Levy
Background: To design a novel anomaly detection and localization approach using artificial intelligence methods using optical coherence tomography (OCT) scans for retinal diseases. Methods: High-resolution OCT scans from the publicly available Kaggle dataset and a local dataset were used by four state-of-the-art self-supervised frameworks. The backbone model of all the frameworks was a pre-trained convolutional neural network (CNN), which enabled the extraction of meaningful features from OCT images. Anomalous images included choroidal neovascularization (CNV), diabetic macular edema (DME), and the presence of drusen. Anomaly detectors were evaluated by commonly accepted performance metrics, including area under the receiver operating characteristic curve, F1 score, and accuracy. Results: A total of 25,315 high-resolution retinal OCT slabs were used for training. Test and validation sets consisted of 968 and 4000 slabs, respectively. The best performing across all anomaly detectors had an area under the receiver operating characteristic of 0.99. All frameworks were shown to achieve high performance and generalize well for the different retinal diseases. Heat maps were generated to visualize the quality of the frameworks’ ability to localize anomalous areas of the image. Conclusions: This study shows that with the use of pre-trained feature extractors, the frameworks tested can generalize to the domain of retinal OCT scans and achieve high image-level ROC-AUC scores. The localization results of these frameworks are promising and successfully capture areas that indicate the presence of retinal pathology. Moreover, such frameworks have the potential to uncover new biomarkers that are difficult for the human eye to detect. Frameworks for anomaly detection and localization can potentially be integrated into clinical decision support and automatic screening systems that will aid ophthalmologists in patient diagnosis, follow-up, and treatment design. This work establishes a solid basis for further development of automated anomaly detection frameworks for clinical use.

10 March 2025 in Eye
Verified
Journal Article
Open access
PDF file
BVBrice Nguedia Vofo
Brice Nguedia Vofo
YSYahel Shwartz
Yahel Shwartz
YCYaacov Cnaany
Yaacov Cnaany
SJShlomit Jaskoll
Shlomit Jaskoll
AKAdi Kramer
Adi Kramer
ICItay Chowers
Itay Chowers
Objectives: This retrospective cohort study aimed to assess the long-term growth and associated risk factors of macular atrophy (MA) in eyes with neovascular age-related macular degeneration (nAMD) treated with intravitreal anti-vascular endothelial growth factor (anti-VEGF) compounds. Methods: Two hundred and six patients initiating anti-VEGF therapy were followed for 8 years using a treat-and-extend protocol. The study analysed correlations between MA growth (by square root transformation measured in infrared images) and clinical parameters, and genetic variants for AMD in the complement and lipid pathways and the ARMS2 gene. Results: Seventy-six patients (n = 92 eyes) were included, with a mean age of 73.9 ± 7.9 years. Eyes received an average of 7.1 ± 3.2 anti-VEGF injections per year. The prevalence of MA increased from 28.3% at baseline to 78.3% at 8 years, exhibiting an average annual growth rate of 0.25 ± 0.22 mm. Correlations were found between MA growth and size, and number of atrophic foci at baseline, and the common ARMS2 variant. Eyes with subretinal fluid (SRF) at baseline showed less foveal atrophy at 8 years compared to those with IRF or both IRF and SRF. No correlation was observed between MA growth and genetic variants in the complement and lipid pathways. Conclusion: Most eyes with nAMD under 8 years of anti-VEGF therapy developed MA, with significant growth. Correlations with baseline MA characteristics and the ARMS2 variant were identified. Further investigation is needed to understand the potential role of complement as a therapeutic target for preventing macular atrophy in nAMD-affected eyes.

29 April 2020 in Eye
Verified
Journal Article
Closed access
PDF file
LTLiran Tiosano
Liran Tiosano
RERita Ehrlich
Rita Ehrlich
YBYoreh Barak
Yoreh Barak
HKHaya Katz
Haya Katz
RPRussell Pokroy
Russell Pokroy
ICItay Chowers
Itay Chowers